A detailed history of Bayesian Capital Management, LP transactions in Si Bone, Inc. stock. As of the latest transaction made, Bayesian Capital Management, LP holds 11,195 shares of SIBN stock, worth $152,475. This represents 0.02% of its overall portfolio holdings.

Number of Shares
11,195
Holding current value
$152,475
% of portfolio
0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$11.93 - $16.34 $133,556 - $182,926
11,195 New
11,195 $144,000
Q2 2023

Aug 14, 2023

BUY
$19.39 - $28.9 $178,388 - $265,880
9,200 New
9,200 $248,000

Others Institutions Holding SIBN

About SI-BONE, Inc.


  • Ticker SIBN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 34,305,000
  • Market Cap $467M
  • Description
  • SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fract...
More about SIBN
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.